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Over 74,000 inguinal hernia repairs were conducted in the 
National Health Service (NHS) between 2008 and 2009, 
making it one of the most commonly performed procedures 
in England.1 The impact of surgery on patients’ quality of 
life (QoL) is considered an important patient reported out-
come measure (PROM) for improving clinical quality and 
since April 2009 it has become routine in some parts of the 
NHS to collect PROMs for inguinal hernia repair.2 Condition-
specific QoL questionnaires are more appropriate than ge-
neric QoL measures for distinguishing between treatment 
alternatives3 and in 2008 a hernia-specific questionnaire 
was published in the US: Heniford et al's Carolinas Comfort 
Scale (CCS).4
The CCS questionnaire is a 23-item self-report ques-
tionnaire that asks about severity of symptoms across eight 
activities using a six-point Likert scale. The original CCS 
validation paper compared six mesh types4 but did not ad-
dress the question of whether the mesh type had an impact 
on CCS QoL scores.
In the present paper we examine the psychometric prop-
erties of the CCS and its utility in distinguishing between 
QoL outcomes of two types of meshes used in hernia repair 
surgery: traditional mesh fixed by sutures (Surgipro™, Co-
vidien, Mansfield, Massachusetts, US) versus a newer self-
adhesive mesh (Parietene™ Progrip™, Sofradim Produc-
tion, Trévoux, France).
Patients and Methods
This study was a cross-sectional survey of long-term QoL 
after mesh repair for inguinal hernia. The primary outcome 
measure was the patients’ report of their QoL as measured 
on the CCS. Secondary outcome measures included recur-
rence of hernia, time until return to work and perioperative 
pain. Background variables were the time since the opera-
tion, body mass index (BMI), demographics (age, ethnic 
group, social class) and free-text handwritten responses 
from patients.
Until November 2007 Surgipro™ mesh was the standard 
type of mesh used at Benenden Hospital and it was replaced 
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ABSTRACT
inTRodUCTion The nhS is required to collect data from patient reported outcome measures (PRoms) for inguinal hernia 
surgery. We explored the use of one such measure, the Carolinas Comfort Scale® (CCS), to compare long-term outcomes for 
patients who received two different types of mesh. The CCS questionnaire asks about mesh sensation, pain and movement 
limitations, and combines the answers into a total score.
PaTiEnTS and mEThodS a total of 684 patients were treated between January 2007 and august 2008 and were followed up 
in november 2009.
RESULTS data on 215 patients who met the inclusion criteria were available (96 patients who received Surgipro™ mesh 
and 119 who received Parietene™ Progrip™ mesh). Recurrence rates were similar in the Surgipro™ group (2/96, 2.1%) 
and Progrip™ group (3/118, 2.5%) (Fisher’s exact test = 1.0). Chronic pain occurred less frequently in the Surgipro™ group 
(11/95, 11.6%) than in the Progrip™ group (22/118, 18.6%) (p<0.157). overall, 90% of CCS total scores indicated a good 
outcome (scores of 10 or less out of 115). a principal component analysis of the CCS found that responses clustered into two 
subscales: ‘mesh sensation’ and ‘pain+movement limitations’. The Progrip™ group had a slightly higher mesh sensation score 
(p<0.051) and similar pain+movement limitations scores (p<0.120).
ConCLUSionS in this study of quality of life outcomes related to different mesh types, the CCS subscales were more sensitive 
to differences in outcome than the total CCS score for the whole questionnaire. Future research should consider using the CCS 
subscales rather than the CCS total score.
TABLE 1 Characteristics of the two groups, showing median 
scores ± interquartile range (range)
Surgipro™ Progrip™ p-value
Perioperative pain
Median ± interquartile 
range (range)
1 ± 1
(0–3)
1 ± 1
(0–3)
<0.749
Return to work
Median weeks ± inter-
quartile range (range)
4 ± 4
(2–36)
4 ± 4
(0–13)
<0.382
CCS total score
Median ± interquartile 
range (range)
0 ± 2.5
(0–115)
0 ± 4.5
(0–53)
<0.152
CCS 'mesh sensation' 
factor
Median (range)
0
(0–40)
0
(0–20)
<0.051
CCS 'pain+movement 
limitations' factor
Median (range)
0
(0–75)
0
(0–33)
<0.120
solely by Progrip™ after this time. The sampling frame con-
sisted of patients who had undergone inguinal hernia repair 
at Benenden Hospital from January 2007 to August 2008. 
The exclusion criteria were bilateral hernias, significant co-
morbidity, patients requiring an additional procedure and 
surgery performed by non-resident surgeons. Patients were 
invited by letter to participate in the study and were pro-
vided with a stamped, addressed envelope for returning the 
completed questionnaires. The survey took about ten min-
utes to complete. Data were anonymised by assigning trial 
numbers. All participants gave written informed consent. 
The study was approved by the West Kent Research Ethics 
Committee (Ref 09/H1103/43).
Heniford et al’s own assessment of the CCS4 found good 
internal reliability (Cronbach’s alpha = 0.979), moderate 
test–retest reliability (with kappa coefficients ranging be-
tween 0.42 and 0.75 for all but one item), moderate concur-
rent validity with the SF-36 health survey (average correla-
tion 0.40) and good discriminant validity compared with the 
SF-36.
Inguinal hernia repair has traditionally been done using 
stitches but in the 1980s the use of mesh began.5 Surgipro™ 
is constructed from polypropylene and needs to be sutured 
or stapled to well defined structures to keep it in place. Pro-
grip™ is a self-adhesive mesh that has been developed to 
reduce postoperative pain for inguinal hernia repair; being 
self-adhesive means that it does not require any sutures to 
keep it in place and is easier to use.6 Progrip™ has not yet 
been compared with other meshes using a validated QoL 
measure.
Statistical analyses
Normally distributed variables were analysed using t-tests 
and Pearson's correlation coefficients. Non-normally dis-
tributed or categorical outcomes were measured using the 
Mann–Whitney U test, Spearman’s correlation coefficients 
and the chi-square test. Analyses were performed using 
SPSS® v16 (SPSS Inc, Chicago, Illinois, US). The signifi-
cance threshold was 0.05 and all p-values are two-tailed.
Internal consistency of the CCS was assessed using 
Cronbach’s alpha. The structure of the CCS was explored 
using principal component analysis. Descriptive statistics 
and the non-parametric Mann–Whitney U test were used 
to determine the sensitivity of the CCS in distinguishing 
between mesh types, patients with or without recurrence 
of hernia, and patients with or without chronic pain. Dif-
ferences in the frequency of hernia recurrence and chron-
ic pain between mesh types were analysed using Fisher’s 
exact test.
Results
Of the 684 patients identified, 334 met the inclusion crite-
ria. The 334 participants were contacted by post and 215 
responded. Overall, 96 of the 151 Surgipro™ patients re-
sponded (response rate: 64%) and 119 of the 183 Progrip™ 
patients responded (response rate: 65%). Forty-two partici-
pants (19.6%) did not answer one or more items from the 
CCS questionnaire. For other outcomes the full dataset was 
analysed but for CCS total scores only the 173 completed 
CCS questionnaires were analysed.
As expected, the time since surgery was significantly 
longer in the Surgipro™ group (p<0.001) but none of the 
other background variables (BMI, social class, race, gender, 
etc) showed any significant difference between the groups.
In the present study the CCS showed good internal re-
liability (Cronbach’s alpha = 0.982). The structure of the 
CCS was investigated using principal component analysis. 
The analysis found that participant responses clustered 
into two subscales (or categories): ‘mesh sensation’ and 
‘pain+movement limitations’.
Table 1 shows the main outcomes for the two patient 
groups with different mesh types. In the Progrip™ group 
the mesh sensation score was slightly higher, approach-
ing statistical significance. 'Pain+movement limitations' 
scores were similar in the two groups.
Recurrence occurred in five cases (2.4% of all pa-
tients). The frequency of recurrence was equivalent 
in the Surgipro™ group (2/96, 2.1%) and the Progrip™ 
group (3/118, 2.5%) (Fisher’s exact test = 1.0). Mann–
Whitney U tests found that those who had a recurrence 
reported significantly more mesh sensation (p<0.016) 
and pain+movement limitations (p<0.002) than those 
who did not have a recurrence. The CCS total score was 
also higher for those who had a recurrence (p<0.003). 
Chronic pain occurred at similar rates in the Surgipro™ 
group (11/95, 11.6%) and the Progrip™ group (22/118, 
18.6%) (p<0.157). Those who experienced chronic pain 
reported significantly more mesh sensation (p<0.001) and 
pain+movement limitations (p<0.001) than those who did 
not have chronic pain.
282 Ann R Coll Surg Engl 2011; 93: 281–285 
MEASUREMENT ISSUES WHEN ASSESSING QUALITy OF LIFE 
OUTCOMES FOR DIFFERENT TyPES OF HERNIA MESH REPAIR
zaboRSzKy GyanTi baRRy SaXby bhaTTaChaRya haSan
TABLE 2 CCS subscales identified by principal component 
analysis after rotation
CCS question Pain+movement 
limitations
Mesh sensation
1a 0.374 0.798
1b 0.684 0.526
2a 0.328 0.863
2b 0.796 0.479
2c 0.682 0.595
3a 0.390 0.836
3b 0.608 0.687
3c 0.578 0.706
4a 0.352 0.796
4b 0.797 0.381
4c 0.707 0.492
5a 0.323 0.798
5b 0.705 0.435
5c 0.667 0.512
6a 0.473 0.749
6b 0.857 0.310
6c 0.812 0.429
7a 0.462 0.789
7b 0.859 0.381
7c 0.859 0.360
8a 0.443 0.717
8b 0.826 0.320
8c 0.776 0.479
Demographics and other background variables
Social classes (professional, intermediate, manual) were 
equally represented in each mesh group (p<0.869). The ma-
jority of patients were Caucasian and there were three non-
Caucasian participants in each group (two Asian, two Afro-
Caribbean, one African and one Turkish). There were three 
women in each group. Only 14 of the 215 respondents were 
NHS patients. This was to be expected because Benenden 
is an independent hospital and sees only a small number of 
NHS patients. A total of 58% of operations were on the right 
side and 42% on the left. There was no significant differ-
ence for any of the five surgeons on any of the outcomes, nor 
did any surgeon perform a significantly different proportion 
of Suripro™ or Progrip™ operations compared with the oth-
er surgeons. The mean BMI in the Surgipro™ group was 
26.56 (standard deviation [SD]: 3.51) and in the Progrip™ 
group it was 26.33 (SD: 3.27) (p<0.570). The mean age in 
the Surgipro™ group was 64.44 (SD: 11.06) and in the Prog-
rip™ group it was 63.29 (SD: 14.28) (p<0.504). The median 
(± interquartile range) time since the operation in years for 
the Surgipro™ group was 2.64 + 0.37 (range: 2.16–3.01) and 
for the Progrip™ group it was 1.86 ± 0.49 (range: 1.07–2.47) 
(p<0.001).
Principal component analysis
The structure of the CCS was investigated using principal 
component analysis (PCA). The rotation method was var-
imax with Kaiser normalisation. Rotation converged in 
three iterations and revealed two components with factor 
loadings >1.0 (Table 2). The resulting subscales show good 
factorability: Kaiser–Meyer–Olkin test = 0.923; Bartlett’s test 
of sphericity (p<0.001); 27% of non-redundant residuals 
were above 0.05. Factor 1 explained 42.5% of the variance 
and factor 2 explained a further 37.4%.
In the CCS, items prefixed with an ‘a’ relate to the sen-
sation of mesh, items prefixed with a ‘b’ relate to pain and 
items prefixed with a ‘c’ relate to movement limitation. Most 
of the items in the first factor were ‘b’ and ‘c’ items, thus 
relating to pain and movement limitations. The second fac-
tor consisted only of question ‘a’ responses. Therefore, all 
items in this factor related to the sensation of mesh. The 
only two ‘b’ and ‘c’ items that loaded on the second factor 
(questions 3b and 3c; see Table 2) were included in the first 
factor because: i) they were nearly as strongly loaded on the 
first factor as the second; ii) including them in the first fac-
tor retained the face validity of the subscales to a greater de-
gree; and iii) further analysis revealed that it made little dif-
ference to outcomes whether 3b and 3c were in the first or 
second factor. Therefore, the two-factor solution appears to 
define the subscales by items relating to either mesh sensa-
tion or pain+movement limitations and all further analyses 
using the CCS subscales reported in the present study in-
clude items 3b and 3c in the first factor with the other ‘b’ and 
‘c’ items. As items 3b and 3c loaded almost equally on both 
of the subscales, future research might seek to replicate the 
PCA of the present study. Item 3c showed weak test–retest 
reliability in the original CCS validation paper4 so its con-
tinued inclusion in the CCS should be considered carefully.
In the standardisation of the CCS4 little information is 
given regarding the PCA except to comment that two fac-
tors were found, the first of which explained approximately 
70% of the variance. This is in contrast to the present study, 
which found that the first factor (pain+movement limita-
tions) accounted for 42.5% of the variance and the second 
factor (mesh sensation) for a further 37.4%. The sample in 
the present study (n=215) is larger than that in the original 
CCS paper (n=136) and therefore more appropriate to the 
statistical power needed for PCA.9 The lack of information 
on the PCA in the original CCS paper4 is unfortunate as this 
makes comparison with the present findings difficult.
Discussion
This study assessed QoL outcomes in two hernia patient 
groups and found that the type of mesh used in their surgical 
repair made only a minor difference to their QoL outcomes. 
The recurrence rate was similar in both mesh groups (Sur-
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Figure 1 CCS total scores for Surgipro™ and Progrip™ 
patients.
CCS total score 
frequency
Surgipro™
n (% of patients)
Progrip™
n (% of patients)
0 54 (63.5%) 46 (51.7%)
1–10 25 (29.5%) 34 (38.2%)
11–20 2 (2%) 2 (2.2%)
21–30 1 (1%) 3 (3.3%)
31–40 0 1 (0.8%)
41–50 2 (2%) 0
≥51 2 (2%) 1 (0.8%)
gipro™ 2.1%; Progrip™ 2.5%), which compares well with 
other studies of open inguinal mesh repair (eg 4.9%).7
The present study found that responses on the CCS 
questionnaire clustered into two subscales: ‘mesh sensa-
tion’ and ‘pain+movement limitations’. This is interesting 
because it suggests that patients tend to experience the 
sensation of mesh in a way that is not necessarily related 
to pain and movement limitations. Furthermore, the mesh 
sensation subscale was able to discriminate between the 
two mesh types despite there being no difference in pain 
and movement limitations in the two mesh groups. These 
findings suggest that the Progrip™ mesh was more notice-
able to patients but that it did not appreciably affect pain and 
limit movement.
The two subscales were also useful in elucidating the 
experiences of patients who experienced a recurrence and 
suggest that recurrence is more characterised by problems 
with pain and movement limitations (p<0.002) than being 
able to sense the surgical mesh (p<0.016). In contrast, while 
the CCS total score was able to discriminate between those 
who had a recurrence compared with those who had not 
(p<0.003), the CCS total score did not reveal which issues 
(sensing mesh versus experiencing pain and movement 
limitations) were more important to these patients.
The response rate in the present study was reasonably 
high (64.5% overall). This is in contrast with the original 
CCS paper,4 which had a response rate of 13% (136 returned 
of 1,048 contacted). In the present study the response rate 
was equivalent in each mesh group, indicating that partici-
pation was not related to mesh type. The original CCS paper 
and the present study both had similar rates of missing data: 
14.7% of the original CCS sample had at least one missing 
item compared with 19.6% for the present study.
Study limitations
Because almost all of the participants were Caucasian, the 
findings might not generalise well to other ethnic groups.
The duration of time since the operation was differ-
ent in the two groups but this is unlikely to account for 
differences in outcomes between the groups. The Sur-
gipro™ repairs were done two to three years prior to 
the survey and the Progrip™ repairs were done one to 
two-and-a-half years prior to the survey. However, other 
research has found that postoperative pain is not a prob-
lem for most hernia patients three months after surgery.7 
Our study found that there was no relationship between 
the duration since the operation and any of the outcome 
measures for either group or for the patients as a whole. 
This means that any group differences were not the result 
of the effect of time.
The sample in the present study reported their QoL 
scores between 2.16 and 3.01 years after surgery and 
more than half of the responses gave the best possible 
score (zero). Although this is positive in clinical terms, it 
means that the CCS subscales are likely to be most use-
ful in finding differences between QoL outcomes in mesh 
types earlier in the post-surgical period when the patients 
are more likely to be symptomatic. This suggests that the 
CCS may be sensitive mainly in relatively symptomatic 
patient groups, such as Hope et al’s.8 See Figure 1.
Comment on distribution of CCS scores
The distribution of responses in the present study was 
very right-skewed. Roughly 90% of CCS total scores were 
less than 10 and 50–60% were zero. The present findings 
require replication using a population that is more symp-
tomatic than that seen in our study, for example patients 
who have had a period of recovery of less than three 
months.
A similar distribution might have inflated the value for 
Cronbach’s alpha in the original CCS paper4 and may ac-
count for the contrast between Heniford et al’s high Cron-
bach’s alpha (0.979) and relatively weaker test–retest co-
efficients (0.42 to 0.75).
Conclusions
The Progrip™ group experienced borderline significantly 
more sensation of mesh and non-significantly more pain 
and movement limitations than the Surgipro™ group. Re-
currence of hernia was found to be similar in the Progrip™ 
and Surgipro™ groups. Principal component analysis sug-
gests that the CCS questionnaire is more sensitive to pa-
tients’ experiences when the subscales are used. Future 
research might benefit from using the three different cat-
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egories of questions (mesh sensation, pain, and movement 
limitations) as three separate subscales in studies where 
each of these three outcomes are of interest in their own 
right.
A wide variety of mesh types are used in different coun-
tries around the world and the present authors suggest that 
using subscales (rather than the CCS total score) is the best 
way of assessing QoL outcomes related to different mesh 
types.
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